We are speaking with preeminent bipolar doctors and researchers around the world to understand and convey breakthrough science in bipolar diagnosis and treatment.
These experts include:
Dr. Ana Andreazza is a Professor in the Departments of Pharmacology & Toxicology and Psychiatry at the University of Toronto. She also holds a Canada Research Chair in Molecular Pharmacology of Mood Disorders and is cross appointed as a collaborator Scientist at the Centre for Addiction and Mental Health. Her research focuses on the understanding of the role of redox modulations and mitochondrial dysfunction in mental illness, especially in mood disorders.
Dr. Olu Alijore is the Director of Clinical Research Core and Professor of Psychiatry at the University of Illinois. He works to understand the pathophysiology of major depressive disorders by studying brain connectivity using MRI techniques. His team is developing innovative ways of discovering brain alterations associated with major depression that may lead to patient-specific targets for intervention and treatment.
Dr. Michael Berk is the Director of the IMPACT Strategic Research Centre at Deakin University in Melbourne, Australia. He serves as both a Visiting Professor at the Guiyang Medical University in China and an Honorary Professor in the School of Public Health and Preventive Medicine at Monash University in Australia. Dr. Berk is primarily interested in the discovery and implementation of novel therapies in addition to the prevention of psychiatric disorders.
Dr. Boris Birmaher is the Endowed Chair in Early Onset Bipolar Disease and Professor of Psychiatry at the University of Pittsburgh School of Medicine and the Director of the Child and Adolescent Bipolar Spectrum Services. In 2022, he was awarded both the Brain & Behavior Research Foundation Ruane Prize for Outstanding Achievement in Child and Adolescent Psychiatric Research and the Institute of Living’s 2022 C. Charles Burlingame Award. Dr. Birmaher specializes in describing the course and treatment of childhood-onset bipolar disorder as well as analyzing the risk factors for mood and anxiety disorders.
Dr. Hilary P. Blumberg is the John and Hope Furth Professor of Psychiatric Neuroscience and Professor of Psychiatry, Radiology and Biomedical Imaging and in the Child Center, at the Yale School of Medicine. As the Director of the Mood Disorders Research Program, she brings together scientists to study the genetic, developmental, and environmental factors that cause mood disorders to develop new methods for early detection, more effective interventions, and prevention of the disorders. Dr. Blumberg utilizes new state-of-the-art brain scanning methods in her most recent work.
Dr. Kate Burdick is the Associate Vice Chair for Research in the Department of Psychiatry as well as Director of the Mood and Psychosis Research Program at Brigham and Women’s Hospital. She is the author of over 100 peer-reviewed manuscripts on major psychiatric disorders with bipolar disorder being a specific focus of her work.
Dr. Nancy Byatt is a perinatal psychiatrist and physician-scientist focused on improving systems of care to promote the mental health of parents and children. She is Professor of Psychiatry, Ob/Gyn and Population & Quantitative Health Sciences at the UMass Chan Medical School. She is also the inaugural Medical Director of MCPAP for Moms, a statewide program that has impacted state and national policies regarding perinatal mental health and increased access to perinatal mental health care for thousands of women.
Dr. Iain Campbell is a Metabolic Psychiatry Research Fellow and University Anatomy Manager at the University of Edinburgh. He is working as a part of the university’s research on ketogenic metabolic therapy for bipolar disorder and attempts to spread awareness and empower advocates within the community.
Dr. Crystal Clark is an Editorial Board Member for the Journal of Clinical Psychiatry and the President of Marcé of North America, an organization dedicated to improving healthcare for perinatal women with mental illness. Dr Clark aims to optimize treatment for pregnant women with Bipolar Disorder. Her most recent research involves studying dosing lamotrigine, lithium, and atypical antipsychotics in pregnancy.
Dr. John F. Cryan is Professor & Chair, Dept. of Anatomy & Neuroscience, University College Cork and was appointed Vice President for Research & Innovation in March 2021. He is also a Principal Investigator in the APC Microbiome Institute. Prof. Cryan’s current research interests include the neurobiological basis of stress-related neuropsychiatric disorders including depression, anxiety and drug dependence. Moreover, his group is also focused on understanding the interaction between brain, gut & microbiome and how it applies to stress and immune-related disorders, including irritable bowel syndrome and obesity and neurodevelopmental disorders such as autism. He is also interested in applying novel approaches to facilitate drug/siRNA delivery to the brain in vivo.
Dr. Faith Dickerson is the Director of Psychology, Research, and Education at Sheppard Pratt, the nation’s largest private, nonprofit healthcare provider. She is a Clinical Professor of Psychiatry at the University of Maryland School of Medicine and an Associate Professor of Psychiatry and Behavioral Sciences at the Johns Hopkins School of Medicine. She has authored more than 300 publications, including one paper that was awarded Best Paper of the Year (2018) from the International Society for Bipolar Disorders. In her research, Dr. Dickerson studies the role of infectious, immune, and microbiome factors in serious mental illness.
Dr. Clare Dolman is a Patient and Public Involvement Lead and Postdoctoral Researcher at King’s College London. She focuses on women with bipolar disorder, researching and providing advice in regards to dealing with bipolar during preconception. She is also involved with the bipolar community as a former Chair and Ambassador of Bipolar UK as well as Co-chair of the Bipolar Commission.
Dr. Jess Fiedorowicz is the Head and Chief of the Department of Mental Health at the Ottawa Hospital and a Professor and Senior Research Chair in Adult Psychiatry at the University of Ottawa. His research focuses on excess mortality, suicide, and vascular disease rates in people with mood disorders such as bipolar. He has published more than 110 peer-reviewed publications.
Dr. Marlene Freeman is a Professor of Psychiatry at Harvard Medical School. She is the Associate Director of the Center for Women’s Mental Health at Massachusetts General Hospital and the Abra Prentice Foundation Chair in Women’s Mental Health at MGH. She is the Medical Director of the Clinical Trials Network and Institute at MGH.
Dr. Michael Freeman is a psychiatrist, psychologist, consultant and former CEO who serves on the faculty of the Department of Psychiatry at the University of California San Francisco School of Medicine. His clinical practice is focused on the treatment of people with mood, anxiety and attention disorders, and his consulting practice is focused on entrepreneurship and performance enhancement coaching. Dr. Freeman’s research addresses the strengths, vulnerabilities, and mental health issues faced by entrepreneurs. He has held CEO and C-level leadership positions in several public and private sector health care organizations. Dr. Freeman brings medical, psychological, prevention/self-care and executive competencies to his clinical and consulting practice.
Dr. Gabriel Fries is an Assistant Professor in the Faillace Department of Psychiatry and Behavioral Sciences at McGovern Medical School at the University of Texas. His research on the epigenetic basis of mood disorders has led him to publish over 120 peer-reviewed articles. His goal is to develop new medicines that can improve the quality of life for people dealing with bipolar and other mood disorders.
Dr. Tiffany Greenwood is the Associate Professor of Psychiatry, Director of the Laboratory for Psychiatric Spectrum Research at University of California San Diego, and the Genetics Coordinator, for the Consortium on the Genetics of Schizophrenia (COGS). Her research focuses on the genetics of dimensional traits that cross diagnostic boundaries and contribute to a spectrum of psychiatric illnesses. She is currently exploring potentially positive traits associated with psychiatric illness, as well as risk prediction models based on genetic and environment interactions.
Dr. Stephen P. Hinshaw is Distinguished Professor of Psychology at UC Berkeley and Professor of Psychiatry and Behavioral Sciences at UC San Francisco. He co-directs the UCSF-UC Berkeley Schwab Dyslexia and Cognitive Diversity Center and the UCSF Child, Teen, and Family Center. He researches mental illness stigma and means of reducing it at multiple levels. He has authored over 410 articles, chapters, and commentaries plus 13 books. His memoir, Another Kind of Madness: A Journey through the Stigma and Hope of Mental Illness, was named Best Book in Memoir/Autobiography from the American BookFest in 2018.
Dr. Georgina Hosang is an Associate Professor and Research Lead in the Unit for Psychological Medicine at the Wolfson Institute of Population Health Centre for Psychiatry and Mental Health. She focuses mainly on bipolar disorder, depression, and psychosis and how they are affected by trauma and stress. She has received many awards for her contributions to the field.
Dr. Louise Howard is a Professor Emerita in Women’s Mental Health at King’s College London and a founder of their Women’s Mental Health Research Group. Her research focuses on improving mental health service policies and practices. Through her research, Dr. Howard has improved guidelines on the identification and treatment of mental illnesses and developed new evidence-based care pathways.
Dr. Kay Jamison is the Co-Director of Mood Disorders Center, Dalio Professor in Mood Disorders and Professor of Psychiatry and Behavioral Sciences at Johns Hopkins Medicine. She co-founded and was director of UCLA’s Affective Disorders Clinic for 10 years, was a distinguished lecturer at Harvard University in 2002 and the Litchfield lecturer at the University of Oxford in 2003. National bestselling author of an Unquiet Mind: A Memoir of Moods and Madness, with her latest book, Robert Lowell: Setting the River on Fire was a Pulitzer Prize Finalist for Biography in 2018. Her book Manic-Depressive Illness, first published in 1990 and co-authored with psychiatrist Frederick K. Goodwin is considered a classic textbook on bipolar disorder.
Dr. Joanna Jarecki is an Assistant Professor in the Department of Psychiatry and Behavioural Neurosciences at McMaster University with a focus on mood disorders. Her approach to mental health care is based on allowing patients to be active participants in their process through empowering and educating them.
Dr. Sheri Johnson is a Professor of Psychology at the University of California Berkeley as well as the Director of the Cal Mania (CALM) Program. She has published five books and over 200 manuscripts, many of which are featured in leading journals such as the Journal of Abnormal Psychology and the American Journal of Psychiatry. She is also a fellow for the Association for Behavioral and Cognitive Therapies (ABCT), the Association for Behavioral Medicine Research, and the American Psychological Society. Dr. Johnson’s work focuses on translational models of bipolar disorder and unipolar depression. She is currently studying how reward sensitivity and emotion-related impulsivity predict the onset and course of disorder, and key outcomes within disorder.
Dr. Ian Jones is a Professor of Psychiatry at the Division of Psychological Medicine and Clinical Neurosciences at Cardiff University and an Honorary Consultant Psychiatrist. His research focuses on bipolar disorder and specifically its relationship with childbirth. His research has established the influence of genetic factors on postpartum episodes and identified specific variants that influence patients’ risk.
Dr. Julie Kauer is the Principle Investigator and namesake of the Kauer Lab at Stanford University School of Medicine’s Department of Psychiatry and Behavioral Sciences. Her lab was one of the first to identify synaptic changes in the brain’s reward circuitry after being exposed to certain drugs.
Dr. John Kelsoe is also the Medical Director of the NIMH clinical research center Special Treatment and Evaluation Program (STEP) at the San Diego VA Medical Center where he specializes in the clinical treatment of chronic and refractory mood disorders. His research focuses on using a variety of molecular genetic methods to identify the specific genes that predispose to bipolar disorder. Dr. Kelsoe directs the Bipolar Genome Study (BiGS), a 13-site consortium focused on identifying genes for bipolar disorders, and co-directs the Psychiatric GWAS Consortium for Bipolar Disorder (PGC-BD), an international collaborative effort designed to identify genes for bipolar disorder in a sample of over 10,000 patients.
Dr. Beny Lafer is an Associate Professor at the Department of Psychiatry at the University of São Paulo Medical School (FMUSP). He is Director of the Bipolar Disorder Research Program (PROMAN) at the Institute of Psychiatry, Hospital das Clinicas, FMUSP. His research focuses on pathophysiological and therapeutic studies related to Bipolar Disorders. He has published over 200 manuscripts and 20 book chapters that have received more than 2200 citations. He is a member of the Editorial Board of the journals Bipolar Disorders, Journal of Affective Disorders and Australian and New Zealand Journal of Psychiatry. He is Editor Emeritus of the RBP Psychiatry.
Dr. Marion Leboyer is the Head of the Psychiatry and Addictology Unit at Hôpitaux Universitaires Henri Mondor and Director of the Genetic Psychiatry Laboratory at Institut Mondor de Recherches Biomédicales. Her most recent work explores the immuno-inflammatory pathways involved in psychiatric disorders.She has given more than 80 lectures in national and international congresses and is the author of more than 300 articles.
Dr. Alex Leow is a Professor in Psychiatry and Bioengineering at the University of Illinois Chicago’s Department of Psychiatry. She collaborates extensively with researchers around the U.S. to investigate a wide range of neuropsychiatric illnesses, including bipolar, late-life depression, Alzheimer’s disease, body dysmorphic disorder, Fragile-X syndrome, and diabetes-related neuroimaging abnormalities.
Dr. Evan Macosko is an Institute Member at the Broad Institute of MIT and Harvard and an Associate Professor and Attending Psychiatrist at Massachusetts General Hospital. His lab focuses on the development and testing of genomics technology to study brain diseases. Recently the lab has developed a tool to uncover pathogenic mechanisms of neuropsychiatric diseases.
Dr. Michael McCarthy in on the faculty of the University of California at San Diego. He sees patients suffering from bipolar disorder at the VA San Diego Healthcare System and is the principal investigator on funded basic and clinical research projects in Bipolar Disorder. His research focuses on circadian rhythms and cell survival in lithium responsive bipolar disorder.
Dr. Colleen McClung is Professor of Psychiatry and Clinical and Translational Science at the University of Pittsburgh. Her research explores the molecular mechanisms of bipolar disorder, major depression and drug addiction. Her laboratory is interested in understanding the molecular mechanisms that underlie psychiatric diseases with an emphasis on the role of circadian rhythms and the genes that make up the clock in reward, anxiety, and mood-related behavior.
Dr. Melvin McInnis is the Thomas B. and Nancy Upjohn Woodworth Professor of Bipolar Disorder and Depression at the University of Michigan Medical School, is the Director of the Heinz C. Prechter Bipolar Research Program and leads a team of over 30 faculty and staff with several projects focused on bipolar disorder. These projects include collaborative programs using induced pluripotent stem cells (iPSC) to model bipolar disorder, the use of mobile technology to monitor and predict mood state changes in the illness, as well as assessments of cognitive capacity of individuals with bipolar disorder.
Dr. Roger McIntyre is currently a Professor of Psychiatry and Pharmacology at the University of Toronto and Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada. He is also Director as well as Co-Chair of the Scientific Advisory Board of the Depression and Bipolar Support Alliance (DBSA). He is involved in multiple research endeavors which primarily aim to characterize the phenomenology, neurobiology, and novel therapeutics of mood disorders. He has been especially interested in identifying innovative, rapid acting psychotropic treatments for mood disorders.
Dr. Erin Michalak is a Professor in the Department of Psychiatry at the University of British Columbia in Vancouver, Canada. She is a member of the Executive Committee for the APEC Digital Hub for Mental Health and the Patient Engagement Methods Clusters Lead for the BC SUPPORT Unit. She founded and currently leads the ‘Collaborative RESearch Team for the study of psychosocial issues in Bipolar Disorder’ (CREST.BD). Dr. Michalak’s medical expertise lies in mood disorders, digital mental health, patient engagement in research, knowledge translation, quality of life, and global mental health.
Dr. David Miklowitz is Professor of Psychiatry in the Division of Child and Adolescent Psychiatry at the UCLA Semel Institute, and a Senior Clinical Research Fellow in the Department of Psychiatry at Oxford University. His research focuses on family environmental factors and family psychoeducational treatments for adult-onset and childhood-onset bipolar disorder. Dr. Miklowitz has published over 300 research articles and 8 books. His book “The Bipolar Disorder Survival Guide” is currently in its third edition and is an international best seller, with over 275,000 copies in print.
Dr. Philip Mitchell, LPC is a therapist in Virginia. He helps teens, families, and adults overcome trauma, manage life’s challenges, and find positive ways to deal with a wide range of emotions. He has extensive experience working with teens who struggle with their emotions and families confronting large, difficult changes. He incorporates art, humor, and role play into therapy sessions.
Dr. Greg Murray is the Director of the University of Melbourne Psychology Clinic and the Chair of the Department of Psychological Sciences at Swinburne University of Technology. His research focuses on mood disorders, circadian rhythms, and personality, and he is recognized as a world expert in bipolar disorder. He has written more than 220 journal articles and has received numerous awards for his work.
Dr. Andrew Nierenberg leads Mass. General Hospital’s Dauten Family Center for Bipolar Treatment Innovation, a center dedicated to finding innovative new treatments, providing high quality clinical care, and educating colleagues, patients, families, and the greater community about Bipolar Disorder. His primary interests are depression, bipolar depression, and novel treatments for mood disorders.
Dr. Robin Nusslock is an Associate Professor of Psychology at Northwestern University, where he also holds appointments in Neurology, Neurobiology, and Psychiatry. He is the recipient of the Rising Star Award from the Association for Psychological Science and the Young Investigator Award from the International Society for Bipolar Disorders. His research uses functional and structural brain imaging to examine brain systems involved in positive and negative emotions, and how these systems are involved in mental health problems, including depression, mania, and substance use.
Dr. James Phelps is a psychiatrist, specializing in bipolar disorders and primary care integration; particularly detection, diagnosis and management in primary care. He specializes in complex mood and anxiety problems and is focused on teaching about non-manic versions of bipolar disorder. He is the author of Why Am I Still Depressed? Recognizing and Managing the Ups and Downs of Bipolar II and Soft Bipolar Disorders (McGraw-Hill, 2006). He has published multiple articles and reviews for peer-reviewed journals, including the Journal of Affective Disorders and Chronobiology International.
Dr. Mary Phillips is Distinguished Professor of Psychiatry, Clinical and Translational Science, and Bioengineering at the University of Pittsburgh, Pittsburgh Foundation-Emmerling Endowed Chair in Psychotic Disorders, Director of the Center for Translational and Developmental Affective Neuroscience, and Director of the Mood and Brain Laboratory. Her research focuses on the identification of neural correlates that underlie the symptoms of specific abnormalities in emotion processing in people with mood disorders.
Dr. Martin Picard is an Associate Professor of Behavioral Medicine and Director of the Mitochondrial Psychobiology Group at Columbia University Irving Medical Center. His lab studies ways in which the mitochondria interact with essential brain-body processes that shape aging biology and sustain health and attempt to accelerate the transition to more sustainable healthcare.
Dr. Kristin Raj is a Clinical Associate Professor of Psychiatry and Behavioral Sciences at Stanford Medicine and a member of the Board of Directors and the Education Committee of the Clinical TMS Society. She specializes in the treatment of mood disorders with expertise in neuromodulation and in the psychopharmacological management of bipolar disorder
Dr. Joshua Rosenblat is a Staff Psychiatrist and Clinician-Researcher at the Mood Disorders Psychopharmacology Unit at Toronto Western Hospital. His focus is treatment-resistant unipolar and bipolar depression and he performs research to develop psychopharmacological interventions, such as ketamine, for mood disorders through the conduction of clinical trials.
Dr. Ayal Schaffer is the Head of the Mood and Anxiety Disorders Program and Deputy Psychiatrist-in-Chief at Sunnybrook Health Sciences Centre, as well as the Vice President of Research for the International Society for Bipolar Disorders. His work deals with the management of bipolar disorder and treatment-resistant depression, analyzing health trends and suicide risk.
Dr. Trudi Seneviratne is the Registrar of the College at Royal College of Psychiatrists and Clinical Director for the Psychological Medicine Clinical Academic Group. She has published numerous papers discussing perinatal mental health conditions She has been honored with many awards such as the President’s Medal of the Royal College of Psychiatrists in 2019.
Dr. Shebani Sethi is a Clinical Assistant Professor in the Department of Psychiatry and Behavioral Sciences and founding Director of the first academic Metabolic Psychiatry Clinical program at Stanford Health. Metabolic Psychiatry is a term she developed to describe the emerging clinical discipline focused on the integrative study and treatment of metabolic dysfunction and the relationship to mental illness. She was awarded funding by the Obesity Treatment Foundation and Baszucki Brain Foundation to study the effectiveness of a low – carbohydrate ketogenic dietary intervention in patients with bipolar illness or schizophrenia with overlapping metabolic abnormalities.
Dr. Daniel Smith, Chair of Psychiatry and Head of Division of Psychiatry at The University of Edinburgh; honorary consultant perinatal psychiatrist with NHS Lothian at the Mother and Baby Inpatient Unit, St John’s Hospital. Professor Smith’s work has been recognized by a number of awards and fellowships, including the American Psychiatric Institute ‘Young Minds in Psychiatry’ International Award for Bipolar Disorder (2007), the Association of European Psychiatrists Research Prize (2007), an NIHR Postdoctoral Fellowship (2008-2011), an Independent Investigator Award from the Brain and Behaviour Research Foundation (2014), the British Medical Journal Innovation Team Award (2014), and a Lister Institute Prize Fellowship (2016).
Dr. Jair C. Soares is a professor and Pat R. Rutherford, Jr. Chair in Psychiatry at McGovern Medical School and as executive director of UTHealth Houston Behavioral Sciences Campus. A Board-certified psychiatrist, he also serves as chief of Psychiatry Services at Memorial Hermann Hospital and LBJ Hospital. Soares also directs the Center of Excellence on Mood Disorders which focuses on the search for the causes and the development of new treatments for mood disorders. The center is comprised of an active research team who specializes in clinical neurosciences (neuroimaging, neurophysiology, cognitive neurosciences, and genetics), as well as clinical psychopharmacology and interventions research.
Dr. Trisha Suppes is a Professor of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine and Director of the Bipolar and Depression Research Program at the VA Palo Alto Health Care System. Her areas of specific expertise include long-term treatment strategies for bipolar disorder, identification and treatment of bipolar II disorder, treatment of those with bipolar disorders and co-morbid conditions, and use of complementary medicine for bipolar disorder.
Dr. Holly Swartz is professor of psychiatry at the University of Pittsburgh School of Medicine. Her research focuses on optimizing psychosocial treatments for mood disorders and the role of psychotherapy in the management of bipolar II disorder. She is well known for her work in evaluating Interpersonal Psychotherapy (IPT) and Interpersonal and Social Rhythm Therapy (IPSRT) as treatments for depression and bipolar disorder.
Dr. Louisa Sylvia is a staff psychologist and Associate Director at Dauten Family Center for Bipolar Treatment Innovation at Massachusetts General Hospital, Director of the Office of Women’s Careers at Massachusetts General Hospital, and an Associate Professor at Harvard Medical School. Dr. Sylvia’s major research interests are developing resiliency and wellness programs for individuals with mood disorders.
Dr. Valerie Taylor is a Professor and the Head of the Department of Psychiatry at the University of Calgary and the namesake of the Taylor Lab. Her research focuses on the interactions between obesity, diabetes, cardiovascular disease, and mental illness, and she has over 180 peer-reviewed publications. She is currently running clinical trials that modify the gut microbiome to treat bipolar disorder.
Dr. Andrea Vassilev is a Doctor of Psychology, Psychotherapist, and the creator of the Overcoming Self-Stigma in Bipolar Disorder program. She focuses on being a mental health advocate for others through her lived experience with bipolar disorder. She also works to end the stigma around bipolar disorder with her countless articles, discussions, and contributions to the community.
Dr. Eduard Vieta is Professor of Psychiatry and Chair at the University of Barcelona and Head of the Department of Psychiatry and Psychology at the Hospital Clinic, where he also leads the Bipolar and Depressive Disorders Program in Barcelona. He has made substantial contributions to the field, with more than 900 original articles, 450 book chapters, and 43 books.
Dr. Nolan Williams is an Associate Professor in the Department of Psychiatry and Behavioral Sciences and the Director of the Stanford Brain Stimulation Lab at Stanford Medicine. His research focuses on clinical neuroscience, and his work has resulted in the world’s first FDA-approved, non-invasive, rapid-acting neuromodulation approach for treatment-resistant depression (SAINT).
Dr. Lakshmi Yatham is a Professor of Psychiatry in the Department of Psychiatry and Director of the Institute of Mental Health at the University of British Columbia. His research focuses on neurobiology and the treatment of bipolar disorder and major depression. He has published over 320 papers in peer-reviewed international journals and received numerous awards for his work.
Dr. Allan Young is the Chair of Mood Disorders and Director of the Centre for Affective Disorders in the Department of Psychological Medicine in the Institute of Psychiatry, Psychology, and Neuroscience at King’s College London. His research focuses on affective disorders and psychopharmacology, specifically the cause and treatments for severe psychiatric illnesses, particularly mood disorders.
Dr. Eric Arden Youngstrom is a professor of Psychology and Neuroscience, and Psychiatry at the University of North Carolina at Chapel Hill. He is also the Acting Director of the Center for Excellence in Research and Treatment of Bipolar Disorder. He consulted on the 5th Revision of the Diagnostic and Statistical Manual (DSM-5) and the International Classification of Diseases (ICD-11). He chairs the Work Group on Child Diagnosis for the International Society for Bipolar Disorders and the Advocacy Task Force.
Dr. Carlos Zarate is Chief, Section on the Neurobiology and Treatment of Mood Disorders and Chief of Experimental Therapeutics and Pathophysiology Branch (ETPB) at the National Institute of Mental Health, and Clinical Professor of Psychiatry and Behavioral Sciences, at The George Washington University.
